Protalix BioTherapeutics, Inc. (DE) Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 12/08/2026 | Mar 2026Filed 13/05/2026 | Sep 2025Filed 13/11/2025 | Jun 2025Filed 12/08/2026 | Mar 2025Filed 13/05/2026 | Sep 2024Filed 13/11/2025 | Jun 2024Filed 14/08/2025 | Mar 2024Filed 09/05/2025 |
|---|---|---|---|---|---|---|---|---|
| $20 | $34 | $18 | $16 | $10 | $18 | $13 | $3.7 | |
| $3.8 | $18 | $2.4 | $0.2 | −$3.6 | $3.2 | −$2.2 | −$4.6 | |
| $0.05 | $0.22 | $0.03 | $0.00 | −$0.05 | $0.03 | −$0.03 | −$0.06 | |
| 83 | 83 | 81 | 81 | 77 | 81 | 73 | 73 |
Trend